News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Wedge Capital Management L L P NC increased its stake in Gildan Activewear, Inc. by 14% during the second quarter, bringing its total holdings to 613,324 shares valued at $31.6 million. This move is part of broader institutional interest, with major investors like Janus …
Sharemaestro market context Price below Trend Line 52 weeks +3.5% · Next-week setup positive 56.7%Morgan Stanley has increased its price target for Agilent Technologies (A) to $175, up from $160, while reiterating an Overweight rating on the stock. This adjustment reflects a positive outlook for the company's financial performance and market position.
Erste Group Bank has lowered its FY2026 EPS forecast for Gilead Sciences to a loss of $0.75 per share, below the consensus estimate of a $0.50-per-share loss. Despite this, analyst sentiment remains a "Moderate Buy" with an average price target of $158.04. Gilead reported …
AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have disclosed a beneficial ownership of 4.15% in agilon health, inc. (AGL) common stock through a Schedule 13G/A filing. This stake amounts to 692,541 shares, with shared voting power over 666,033 shares …
Wasatch Advisors LP reduced its stake in Agilysys, Inc. by 1.7% in the second quarter, selling 16,310 shares but still holding 937,420 shares valued at $98 million. Agilysys reported better-than-expected quarterly revenue of $87.68 million and earnings of $0.49 per share, marking a 14.3% …
Gilead Sciences has renewed its collaboration with Israel-based Nucleai to apply Nucleai's AI-powered Tissue Intelligence platform for spatial biomarker generation and translational insights in Gilead's antibody-drug conjugate (ADC) clinical development programs. Nucleai's platform analyzes large datasets of H&E and IHC images, integrating computational pathology, …
agilon health (AGL) significantly beat revenue and profitability estimates in Q2, though its share price dropped. Management attributed strong financials to operational improvements and AI investments. Analysts questioned the sustainability of improved medical margins, seasonality in cost trends, and the sources of medical cost …
Gilat Satellite Networks reported a 17% year-over-year revenue increase and 31% growth in adjusted EBITDA for Q2 2026, driven by higher-margin integrated solutions. The company plans a $157.5 million acquisition of Comtech to double its defense revenue and expand its offerings. Despite customer concentration …
Gilead Sciences (NASDAQ: GILD) has significantly outpaced the market over the past two decades, yielding an average annual return of 11.31%. An initial investment of $1000 in GILD stock 20 years ago would now be valued at $8,488.28. This performance highlights the substantial impact …
Ermenegildo Zegna NV (ZGN) shares recently declined by 4.4% and are currently trading at $14.15, which is 18.5% above its GF Value™ estimate, indicating it is overvalued. Despite a strong GF Score™ of 82/100, driven by high momentum and growth, the company faces challenges …
Gilead Sciences, Inc.'s EVP, Keeley M Cain Wettan, reported the conversion of 6,002 restricted stock units (RSUs) into common stock on August 10, 2026. Of these, 2,908 shares were withheld at $133.06 per share to cover exercise price or tax liability. Following this transaction, …
Sharemaestro market context Price above Trend Line 52 weeks +42.5% · Next-week setup positive 55.2%Gilead Sciences Inc. (GILD) saw its stock advance by 2.04% to $135.77 on Tuesday, outperforming the broader market which experienced a decline. The S&P 500 Index fell 0.32% and the Dow Jones Industrial Average fell 0.34% on the same trading day. Gilead Sciences Inc. …
Options traders are showing strong institutional conviction for upside in Gilead Sciences through 2026, with a high call bias and significant call spread activity. This suggests investors expect the stock to rise to the $135-$150 range, supported by strong technicals and fundamentals despite some …
Gildan Activewear Inc. (GIL) saw its stock rise by 1.68% to C$81.50 on Tuesday, outperforming the Canadian market as the S&P/TSX Composite Index rose by 0.05%. Despite the gain, the company's stock closed 18.9% below its 52-week high achieved on February 13th.
Agilent Technologies Inc (A) has achieved an exceptional GF Score of 97 out of 100, indicating a high potential for market outperformance. This score is driven by strong rankings in financial strength (7/10), profitability (9/10), growth (10/10), GF Value (9/10), and momentum (8/10). The …
Agilent Technologies Inc. has launched OpenLab Sync, a new Lab Execution System (LES) designed to digitalize scientific workflows from method design to execution in laboratories. This system aims to enhance consistency, data integrity, and audit readiness in regulated environments by offering guided, digital workflows …
Yechiel Amir Ofek, a Director at Gilat Satellite Networks (NASDAQ: GILT), exercised stock options worth $40,419 for 8,334 shares on August 10, 2026. The article details Gilat Satellite Networks' financial performance, including revenue growth, debt management, and valuation metrics, while also explaining the significance …
BNP Paribas has downgraded Ermenegildo Zegna N.V. (ZGN) from "Neutral" to "Underperform" and set a new price target of $12.20. This analyst action reflects a less optimistic outlook on the luxury apparel company's stock. The article also provides recent news headlines related to Ermenegildo …
Handelsbanken Fonder AB decreased its stake in Gilead Sciences by 7.2% in the second quarter, now holding 975,089 shares valued at approximately $123.2 million. Other institutional investors have adjusted their positions, with collective institutional ownership standing at 83.67%. Gilead Sciences reported strong quarterly revenues …
Citigroup has upgraded its rating for Agilon Health, Inc. from "Sell" to "Neutral" and simultaneously increased its target price for the company's stock to $115 from $105. This adjustment reflects a more optimistic outlook on Agilon Health's financial prospects by the analyst firm. The …
Janus Henderson Group PLC significantly reduced its stake in Agilysys, Inc. (AGYS) by 81.9% in the first quarter, selling over 53,000 shares. Despite this institutional selling and recent insider sales by CEO Ramesh Srinivasan and other insiders, analysts maintain a "Moderate Buy" rating with …
Needham has raised its target price for Agilysys Inc. (AGYS) shares to $135 from $130. This update reflects an analyst's revised valuation for the company. The article, sourced from Reuters, provides this key financial news.
E. Ohman J or Asset Management AB significantly reduced its stake in Gilead Sciences, Inc. (NASDAQ:GILD) by 88.3% during the second quarter, now holding 44,792 shares valued at $5.66 million. Despite this, other institutional investors have slightly increased their holdings. Analysts currently rate GILD …
The Rosen Law Firm is investigating potential securities claims on behalf of Gildan Activewear Inc. (NYSE: GIL) shareholders. This investigation follows a short seller report from Jehoshaphat Research alleging misleading business information and financial engineering by Gildan, which caused the company's NYSE-listed shares to …
Sharemaestro market context Price below Trend Line 52 weeks +3.5% · Next-week setup positive 56.7%Needham has increased its price target for Agilysys Inc (NASDAQ:AGYS) to $135 from $130, maintaining a Buy rating, following investor meetings and the company's strong performance, including the rollout of its property management system at over 2,000 Marriott hotels. Agilysys reported record bookings and …
Gilat Satellite Networks (GILT) has announced its Annual General Meeting of Shareholders for September 8, 2026, in Petah Tikva, Israel. Key agenda items include increasing authorized share capital from 90 million to 150 million ordinary shares, re-electing five directors, and approving significant amendments to …
Gilat Satellite Networks director Amir Yechiel Ofek recently sold 3,923 shares of GILT stock for approximately $44,761. The company's shares opened at $11.23, trading below its 50-day and 200-day moving averages, while institutional investors hold 35.72% of the stock. Analysts maintain a "Moderate Buy" …
Sharemaestro market context Price below Trend Line 52 weeks +8.6%Needham & Company LLC has raised its price target for Agilysys (NASDAQ:AGYS) to $135 from $130, maintaining a "buy" rating and implying a potential upside of 24.33%. This comes after Agilysys surpassed quarterly earnings and revenue expectations. Despite significant insider selling, institutional investors hold …
Israeli firm Gilat Satellite Networks has developed new AI-based technology to combat satellite communication interference, a growing concern in military operations. The technology, demonstrated to handle unpredictable conditions and uncooperative signals, has shown a significant improvement in noise detection and suppression. This development aims …
Gilat Satellite Networks (GILT) reported strong financial results for the first half of 2026, with revenues increasing by 18.3% to $233.1 million and net income rising to $13.4 million. The company attributes this growth to its Commercial, Defense, and Peru segments, alongside improved gross …
Sharemaestro market context Price below Trend Line 52 weeks +8.6%Search by ticker symbol or company name and select a result to open its chart.